WEST PHARMACEUTICAL SERVICES, INC. Proceeds from Sale and Maturity of Marketable Securities
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2017-02-28
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2015-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for fiscal 2016 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for fiscal 2014 was $16.80M, a 12.04% decline from fiscal 2013.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from sale and maturity of marketable securities for fiscal 2013 was $19.10M, a 58.11% decline from fiscal 2012.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 10-K · filed 2017-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 derived: sum of 2 quarters · filed 2015-11-02 | $0.00 10-Q · filed 2015-11-02 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $0.00 10-Q · filed 2015-08-03 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $8.50M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $8.50M derived: sum of 3 quarters · filed 2017-02-28 | $11.80M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $8.50M derived: sum of 2 quarters · filed 2017-02-28 | $11.80M derived: sum of 3 quarters · filed 2017-02-28 | $16.80M 10-K · filed 2017-02-28 |
| 2014-09-30 | $8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $11.80M derived: sum of 2 quarters · filed 2015-11-02 | $16.80M 10-Q · filed 2015-11-02 | $17.60M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $8.30M 10-Q · filed 2015-08-03 | $9.10M derived: sum of 3 quarters · filed 2016-02-26 | $13.70M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $5.00M 10-Q · filed 2015-05-06 | $5.80M derived: sum of 2 quarters · filed 2016-02-26 | $10.40M derived: sum of 3 quarters · filed 2016-02-26 | $14.50M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $5.40M derived: sum of 2 quarters · filed 2016-02-26 | $9.50M derived: sum of 3 quarters · filed 2016-02-26 | $19.10M 10-K · filed 2016-02-26 |
| 2013-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $8.70M derived: sum of 2 quarters · filed 2014-11-03 | $18.30M 10-Q · filed 2014-11-03 | $31.80M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $13.70M 10-Q · filed 2014-08-01 | $27.20M derived: sum of 3 quarters · filed 2015-02-25 | $32.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $9.60M 10-Q · filed 2014-05-08 | $23.10M derived: sum of 2 quarters · filed 2015-02-25 | $27.90M derived: sum of 3 quarters · filed 2015-02-25 | $50.40M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $18.30M derived: sum of 2 quarters · filed 2015-02-25 | $40.80M derived: sum of 3 quarters · filed 2015-02-25 | $45.60M 10-K · filed 2015-02-25 |
| 2012-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $27.30M derived: sum of 2 quarters · filed 2013-11-04 | $32.10M 10-Q · filed 2013-11-04 | |
| 2012-06-30 | $22.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $27.30M 10-Q · filed 2013-08-05 | ||
| 2012-03-31 | $4.80M 10-Q · filed 2013-05-06 | |||
| 2011-12-31 | $15.60M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |